J.W. Cole Advisors, Inc. Novo Nordisk A S Transaction History
J.W. Cole Advisors, Inc.
- $3.14 Billion
- Q1 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 16,266 shares of NVO stock, worth $793,130. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,266
Previous 10,277
58.28%
Holding current value
$793,130
Previous $884,000
27.71%
% of portfolio
0.04%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding NVO
# of Institutions
1,745Shares Held
338MCall Options Held
11MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$921 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$721 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$604 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$601 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$579 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $110B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...